DR. CORINNE KEATING DEVEREUX, MD
Radiology at Greenfield Ave, Yonkers, NY

4833132, May 23, 1989

Mar 23, 1987

7/030283

Charles R. Spillert - West Orange NJ
Corinne Devereux - Bronxville NY
Eric J. Lazaro - Jersey City NJ

University of Medicine and Dentistry of New Jersey - Newark NJ

A61K 31635, A61K 31505

514158

There is disclosed a process for treating a warm-blooded animal wherein there is administered to the warm-blooded animal a therapeutically effective amount of composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptable base, 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine, a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine with a pharmaceutically acceptable acid and mixtures thereof. The composition is useful to treat a fibrosarcoma (SAD. sub. 2) tumor in warm-blooded animals.

4661478, Apr 28, 1987

Sep 27, 1984

6/655080

Charles R. Spillert - West Orange NJ
Corinne Devereux - Bronxville NY
Eric J. Lazaro - Jersey City NJ

University of Medicine and Dentistry of New Jersey - Newark NJ

A61K 31635, A61K 31515, A61K 31505

514158

There is disclosed a process for treating a warm-blooded animal subjected to barbituate anesthesia to potentiate effects thereof wherein there is administered to the warm-blooded animal a therapeutically effective amount of a composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptable base, 2,4-diamino-5-3-(3,4,5-trimethoxybenzyl) pyrimidine, a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine with a pharmaceutically acceptable acid and mixtures thereof.

4632920, Dec 30, 1986

Sep 27, 1984

6/655079

Charles R. Spillert - West Orange NJ
Corinne Devereux - Bronxville NY
Eric J. Lazaro - Jersey City NJ

University of Medicine & Dentistry of New Jersey - Newark NJ

A61K 31635

514158

There is disclosed a process for treating a warm-blooded animal following burn injury wherein there is administered to the warm-blooded animal a therapeutically effect amount of a composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptable base, 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine, a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrmidine with a pharmaceutically acceptable acid and mixtures thereof.

4698335, Oct 6, 1987

Sep 27, 1984

6/655227

Charles R. Spillert - West Orange NJ
Corinne Devereux - Bronxville NY
Eric J. Lazaro - Jersey City NJ

University of Medicine & Dentistry of New Jersey - Newark NJ

A61K 31635

514158

There is disclosed a process for treating a warm-blooded animal to be subjected to radiotherapy or chemotherapy wherein there is administered to the warm-blooded animal a therapeutically effective amount of a composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptable base, 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine, a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzene) pyrimidine with a pharmaceutically acceptable acid and mixtures thereof.

4632919, Dec 30, 1986

Sep 27, 1984

6/655145

Charles R. Spillert - West Orange NJ
Corinne Devereux - Bronxville NY
Eric J. Lazaro - Jersey City NJ

University of Medicine & Dentistry of N.J. - Newark NJ

A61K 31635, A61K 31505

514158

There is disclosed a process for prolonging recalcification, prothrombin and thrombin times of human plasma which comprises administering to a warm-blooded animal a composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of 5-methyl-3-sulfanilamidoisoxazole with a pharmaceutically acceptable base, 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine, a salt of 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine with a pharmaceutically acceptable acid and mixtures thereof.